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Abstract Bridging the gaps between experimental systems
on different hierarchical scales is needed to overcome
remaining challenges in the understanding of muscle con-
traction. Here, a mathematical model with well-character-
ized structural and biochemical actomyosin states is
developed to that end. We hypothesize that this model
accounts for generation of force and motion from single
motor molecules to the large ensembles of muscle. In
partial support of this idea, a wide range of contractile
phenomena are reproduced without the need to invoke
cooperative interactions or ad hoc states/transitions. How-
ever, remaining limitations exist, associated with ambigu-
ities in available data for model definition e.g.: (1) the
affinity of weakly bound cross-bridges, (2) the character-
istics of the cross-bridge elasticity and (3) the exact
mechanistic relationship between the force-generating
transition and phosphate release in the actomyosin ATPase.
Further, the simulated number of attached myosin heads in
the in vitro motility assay differs several-fold from duty
ratios, (fraction of strongly attached ATPase cycle times)
derived in standard analysis. After addressing the men-
tioned issues the model should be useful in fundamental
studies, for engineering of myosin motors as well as for
studies of muscle disease and drug development.
Keywords Striated muscle  Single molecules  In vitro
motility assay  Myosin  Actin  Monte-Carlo simulation
Introduction
It is well-known that contraction of striated muscle
(skeletal muscle and heart) results from interactions, driven
by ATP-turnover, between myosin and actin (Ma˚nsson
et al. 2015). The arrangement of these proteins in large
ordered ensembles, sarcomeres, in striated muscle ensures
highly optimized function as indicated by convergent
evolution in organisms as distant as cnidarians (e.g. jelly-
fish) and mammals (Steinmetz et al. 2012). Despite intense
studies, the basis for the high level of perfection of the
ordered system remains poorly understood (Batters et al.
2014; Ma˚nsson et al. 2015). This fact is not only of fun-
damental importance. Increased insight in this regard
would also benefit the understanding and treatment of
diseases, e.g. cardiomyopathies (Ferrantini et al. 2009;
Frey et al. 2012; Green et al. 2016; Marston 2011; Spudich
2014; Teekakirikul et al. 2012), a leading cause of sudden
death in young people, and heart failure, a leading cause of
hospitalization and mortality where myosin-active drugs
may be useful (Malik et al. 2011; Teerlink et al. 2011). One
reason for remaining knowledge gaps is the difficulty to
integrate experimental results as well as key concepts, from
studies using different techniques and hierarchical scales
ranging from single molecules over small ensembles to
muscle (Baker et al. 2002; Ma˚nsson et al. 2015; Walcott
et al. 2012). One tool that would be valuable in this regard
is a mathematical model that bridges the gap while being
both simple enough to effectively aid data interpretation
and sufficiently detailed to incorporate biochemical acto-
myosin states that are critical for function.
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The in vitro motility assay (Kron and Spudich 1986) is
a powerful small ensemble assay that is increasingly used
for studies of muscle disorders with potential usefulness
in drug development (Aksel et al. 2015; Kohler et al.
2003; Li and Larsson 2010; Sommese et al. 2013; Song
et al. 2011). Generally, fluorescence-labeled actin fila-
ments are propelled by surface adsorbed myosin mole-
cules or myosin motor fragments obtained by mild
proteolysis or expression in cell systems (Kron et al.
1991). The assay may be combined with genetic engi-
neering (Kubalek et al. 1992; Schindler et al. 2014;
Sommese et al. 2013; Tsiavaliaris et al. 2004) and has
been adapted for single molecule studies e.g. using optical
tweezers (Finer et al. 1994), nm tracking techniques
(Wang et al. 2013) or cantilever systems (Ishijima et al.
1996; Kalganov et al. 2013) to measure pN–nN forces
and nm displacements.
Mathematical models that cover the scale from single
molecules to large ensembles are required to relate results
of the in vitro assays to molecular properties on the one
hand and muscle contractile function in health and disease
on the other. Currently, however, key data obtained from
small ensembles and the large ensembles of muscle are
generally interpreted using different theoretical frame-
works. For instance, elasticity is central in muscle func-
tion and, therefore, also in classical models (Hill 1974;
Huxley 1957; Huxley and Simmons 1971) of muscle
contraction where changes in state of one head or a group
of heads are assumed to influence the strain, and thereby
strain-dependent kinetics, of other heads. In contrast,
certain in vitro motility assay data are interpreted using
models (Uyeda et al. 1990; Wang et al. 2013) without
such elastic coupling between motors. Furthermore, the
precise geometrical arrangement of the myofilament lat-
tice in muscle is absent in the different versions of the
in vitro motility assay. On the other hand, this arrange-
ment is implicit in most models of muscle contraction
(Eisenberg and Hill 1978; Huxley 1957; Ma˚nsson 2010)
since the ensemble-averaged forces, turnover rates etc.
that are considered in these models rely on the actin-
myosin organization of the muscle sarcomere.
Efforts have been made to include elastic coupling
between cross-bridges in models for actomyosin behavior
in the vitro motility assay (Baker et al. 2002; Erdmann and
Schwarz 2012; Hilbert et al. 2013; Ishigure and Nitta 2015;
Pate and Cooke 1991; Walcott et al. 2012). Studies have
also addressed the role of the hierarchical organization
using spatially explicit models of large ensembles of actin
and myosin (Campbell 2009; Tanner et al. 2007) with aims
to elucidate the roles of the geometrical arrangement in
specific situations. However, these models (Baker et al.
2002; Campbell 2009; Erdmann and Schwarz 2012; Hilbert
et al. 2013; Ishigure and Nitta 2015; Pate and Cooke 1991;
Tanner et al. 2007; Walcott et al. 2012) have used sim-
plified representations of the actin-myosin ATP turnover
mechanism. For instance, like several previous large-
ensemble muscle models (e.g. (Duke 1999; Eisenberg et al.
1980; Ma˚nsson 2010; Pate and Cooke 1989; Persson et al.
2013), the weakly bound actomyosin state has not been
explicitly included. Neither has the phosphate release step
been separated from the main force-generating event (‘‘the
power-stroke’’). Further, the full scale from single mole-
cules to the large ensembles of muscle has not been con-
sidered. All this makes it difficult to use the models for
elucidating e.g. disease mechanisms (see above) or drug
effects that involve stabilization of a specific biochemical
state suggested by solution kinetics studies.
With the aim to overcome current limitations, we here
investigate to what extent a statistical actomyosin cross-
bridge model of classical type (Hill 1974; Huxley 1957)
with detailed biochemical cycle but without explicit geo-
metrical details can account for contractile behavior from
single molecules to large ensembles of muscle. Due to the
ample evidence for cooperativity or emergent phenomena
during active lengthening and under conditions of varied
activation (Brunello et al. 2007; Edman and Flitney 1982;
Gordon et al. 2000; Linari et al. 2015; McKillop and
Geeves 1993; Rassier 2012b) the studies focus on cases of
full activation and isometric contraction or shortening
contraction. However, it is briefly considered how activa-
tion mechanisms may be introduced as well as certain
mechanisms that are specific to lengthening contractions.
The model is defined on basis of kinetic parameter values
from the literature obtained under as coherent conditions as
possible (with regard to temperature, ionic strength, muscle
type etc.).
As a basis for the investigations, it is hypothesized that
such a coherently defined actomyosin model accounts for
generation of force and motion from single molecules to
the ordered arrays in muscle without the need to invoke
emergent phenomena and/or consider structural details.
This hypothesis was largely supported as it was found that
the model, surprisingly well, approximates key contractile
phenomena on different scales. However, there were
remaining limitations in details of model performance.
These limitations provide mechanistic insights as discussed
in detail below. They also suggest improvements in the
details of the model as well as new experimental studies.
After such further developments the model should be
useful in studies of muscle diseases and in guiding asso-
ciated drug development. We also consider possible use-
fulness in guiding engineering of myosin motors (Amrute-
Nayak et al. 2010; Nakamura et al. 2014; Schindler et al.
2014; Tsiavaliaris et al. 2004) e.g. for optimized use in
nanotechnological applications (Kumar et al. 2016; Ma˚n-
sson 2012; Nicolau et al. 2016).
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Materials and Methods
For large ensembles of myosin motors, the model was
implemented by solving differential equations in state
probabilities using Simnon software (version 1.3; SSPA,
Gothenburg, Sweden). For small ensembles and single
molecules, the model was implemented using a Monte-
Carlo approach (Gillespie 1976). Simulation details are
given in the Supporting Information.
In vitro motility assay velocities (vf) as function of the
number (N) of available myosin head were fitted to the
equation (Uyeda et al. 1990):
vf ¼ v1ð1 1 fð ÞNÞ ¼ v1ð1 1 fð ÞqdlÞ ð1Þ
Here, v? is the sliding velocity for infinitely long fila-
ments, f is a myosin duty ratio (fraction of ATP-turnover
time spent in strongly bound states). The quantity N = qdl,
where l is filament length, q is the surface density of active
myosin heads and d is the width of band around the actin
filament where myosin heads reach their attachment sites
on the filament. Previously we found, using trimethyl
chlorosilane-coated surfaces, that q & 5000 lm-2 and
d & 30 nm. Equations were fitted to simulated data using
non-linear regression (Marquardt–Levenberg algorithm;
GraphPad Prism v. 6.05).
Theory
The model is based on the kinetic scheme in Fig. 1a with
abbreviations of different states explained in the legend.
The total amplitude of the force-generating power-stroke
(‘‘step-length’’; from state AM*DL to states AMD and AM)
was taken as 7.7 nm, slightly modified from the value of
7.35 nm in a recent model for large ensembles (Persson
et al. 2013).The value of 7.7 nm is consistent with an 8 nm
myosin step suggested in (Kaya and Higuchi 2010) based
on optical tweezers studies that did not distinguish sub-
steps. By assuming a final sub-step of 1 nm (Capitanio
et al. 2006) the total value of 7.7 nm suggests a first sub-
step of 6.7 nm. These step-lengths are directly reflected in
the diagrams in Fig. 1b that illustrate the free energy of
different states as function of the variable x. This variable
represents the distance between a reference point on the
myosin molecule and the nearest actin filament site, with
x = 0 nm when force in the AMD/AM state is zero. The
free energies of two different generic states, i and j, are
related to the equilibrium constant (Kij(x)) and forward and
backward rate constants (kij(x) and kji(x)) as follows:




All rate functions used are defined in detail the Sup-
plementary Theory and related parameter values are given
in Supplementary Tables S1 and S2. We did not explicitly
include an intermediate AM*DP-state (Dantzig et al. 1992)
(between the AMDP and the AM*DL states) in the free
energy diagrams in Fig. 1b. However, such a state is
implicit in the strain-dependence of the rate constant for
the weak-to-strong (AMDP to AM*DL) transition (Sup-
plementary Eq. S2) and the reversal of this transition
(Supplementary Eqs. S3 and S4). The strain-dependence of
free energy of the implicit AM*DP state is assumed to be
identical to that for the AM*DL state (Fig. 1b), but dis-
placed upwards by a quantity kBT ln(KC/[Pi]).
The MgATP-induced detachment (k2(x)) was generally
taken as strain-dependent, an issue that is discussed below
(see also Supplementary Theory).
The effect of including a fraction of non-cycling ‘‘dead’’
myosin heads (e.g. treated with N-ethyl maleimide; NEM)
in the in vitro motility assay (e.g. Aksel et al. 2015; Bing
et al. 2000) was simulated by introducing two additional
states in the model, one attached to actin (AMD; ‘‘D’’ for
‘‘dead’’) and one detached (MD). The detachment kinetics
was taken from optical tweezer results for HMM-actin in
rigor (Nishizaka et al. 2000). The MD and AMD states were
assumed to have free-energy diagrams similar to that of the
MT (not varying with x) and AM state, respectively with a
difference of 18 kBT (unless otherwise stated) between the
free energy minima of the states. The kinetic scheme gov-
erning the transitions between the AMD and MD states was
assumed separated from the scheme in Fig. 1a. That is, the
only allowed transitions for non-cycling heads were
between the MD and AMD states. For further details, see
Supplementary Methods.
The present model assumes maximum Ca2? activation
as defined in detail in the Supplementary Theory. It is also
assumed (Fig. 1c) that a maximum of one site on the actin
filament is within reach of any myosin cross-bridge and
that the thin/actin and thick/myosin filaments are infinitely
stiff. Furthermore, only one of the two globular units
(heads) of each myosin molecule is assumed to bind
simultaneously to actin. The neighboring sites on the actin
filament are generally assumed to be separated by 36 nm
but in some control simulations, we consider the effects of
assuming three independent sites per 36 nm.
All strongly bound myosin heads are assumed to have a
stiffness of 2.8 pN/nm whereas the stiffness of weakly
bound myosin heads is taken as 0.02 pN/nm. This is con-
sistent with the weak non-specific attachment and appre-
ciable rotational freedom of the latter type of heads. In
most cases, we assume similar stiffness for positive and
negative x but we also consider non-linear elasticity of
strongly bound heads with cross-bridge stiffness, 0.25 pN/
nm for x\ 0 nm (see Supplementary Theory).
The model is defined on basis of kinetic parameter
values from the literature, obtained under as coherent
conditions as possible (with regard to temperature
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[*30 C]), ionic strength [130–200 mM], muscle type
[fast rabbit skeletal muscle] etc.). In the case of deviations
from the pre-selected conditions we either make correc-
tions, when possible, or discuss the consequences of the
deviations (Supplementary Tables S1 and S2 and Supple-
mentary Theory).
Results
Simulation of muscle contractile properties gave similar
results whether using numerical solution of differential
equations or Monte-Carlo simulations (Supplementary
Fig. S1). This suggests that the two approaches can be used
interchangeably for large ensembles. Unless otherwise
stated, the parameter values in Supplementary Tables S1
and S2 were used and [MgATP] = 5 mM. The value used
for k5 (Fig. 1a) required particular considerations as dis-
cussed below and in Supporting Theory.
Using standard parameter values, the kinetic scheme in
Fig. 1a predicts that Vmax & 89 s-1 for actomyosin
ATPase in solution at saturating [actin] (Supplementary
Eq. S14). This is similar to 86 s-1 in experiments (tem-
perature correction from (Brenner and Eisenberg 1986)
assuming Q10 = 2.7). With an effective actin concentration
of 1–3 mM (Brenner et al. 1986), a binding constant
Kw = 1 corresponds to a binding constant Ka in solution in



















Lever arm              
myosin head   
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Fig. 1 Key elements of model. a Kinetic scheme showing myosin
(M) and actomyosin (AM) biochemical states with MgATP (T),
MgADP (D) and/or inorganic phosphate (P/Pi) at the active site. The
MDP and AMDP states, on the one hand, and the AM*DL and
AM*DH states, on the other, are assumed to be in rapid equilibrium
with equilibrium constants Kw(x) and KLH(x), respectively. The
AM*DL state is a strongly bound, start-of-power-stroke state. Several
rate constants ki as well as equilibrium constants Ki vary with the
elastic strain in the cross-bridge. b The free energy of all states as
function of x (see text). Insets schematically illustrate different
structural states of myosin head and lever arm at free-energy minima.
c Schematic illustration of an in vitro motility assay where myosin
motor fragments (heavy meromyosin; HMM) are adsorbed to a
surface. The one-head, single-site assumption is illustrated: only one
of the two myosin heads can bind to actin and binding is possible only
to one site (dark) per 36 nm helical half-repeat of the actin filament.
Key parameter values are given in Supplementary Tables S1 and S2
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0.4–1.2 mM for the actomyosin ATPase (actin concentra-
tion for half-maximum ATPase) (Supplementary Eq. S15).
This is similar to experimental results (Woledge et al.
1985). On the other hand, if Kw is an order of magnitude
higher (e.g. Kw = 12), then Ka would be overestimated in
the model, being in the range 4–12 9 103 M-1 with
KM & 0.04–0.12 mM. However, as pointed out below, if
we assume Kw = 12, this gives better fit of the model to
the force–velocity relationship and other mechanics data.
Whereas Kw = 12 leads to overestimation of Ka if the
effective actin concentration is 1–3 mM it is important to
note that there is some uncertainty in the latter value (see
‘‘Discussion’’ section).
The model predicts two length steps in single molecule
recordings (Fig. 2; cf. Capitanio et al. 2006) with average
amplitudes of 6.55 ± 3.33 nm (standard deviation;
n = 994) and 1 nm, respectively. Here, the first step varies
in amplitude due to a spectrum of x-positions for initial
cross-bridge attachment. The results are consistent with
total amplitude of *8 nm at low optical trap stiffness
(Kaya and Higuchi 2010). In terms of the model, the
6.6 nm step directly corresponds to the difference in
x-position of the free-energy minima for the AM*DL and
the AM*DH states (Fig. 1b) whereas the 1 nm step corre-
sponds to the x-difference between the minimum free
energy of the AM*DH and the AMD/AM states. This
clearly illustrates the correspondence between single
molecule length-step data and free-energy diagrams of the
Hill type (Hill 1974).
The two length-steps separate the tension response into
two phases (Fig. 2a). The duration of the first phase (t1) is
independent of [MgATP] whereas the second phase exhi-
bits [MgATP]-dependent duration (t2; Fig. 2b) with rate
constant proportional to [MgATP] at low [MgATP]
(Fig. 2c; cf. Capitanio et al. 2006).
The load-dependence of the ATP induced detachment
rates in single molecule recordings shows similarities to
experiments (Capitanio et al. 2012; Sung et al. 2015) but
differs in the quantitative details (Supplementary Figs. S2A
and S2B). This may be partly attributed to different myosin
preparations used in the experiments and assumed in the
simulations (one-headed vs two-headed; see legend of
Supplementary Fig. S2 and ‘‘Discussion’’ section). As in
(Capitanio et al. 2012), a new detachment process became
important in simulations with imposed resistive loads.
However, this process, associated with Pi-binding in the
model, was appreciably slower than in the experiments and
was not analyzed in detail (see further ‘‘Discussion’’
section).
The model reproduces key aspects of experimental
in vitro motility assay results. The general shape of the
relationship between velocity and the number of available
myosin heads (N; proportional to filament length) is rea-
sonably well predicted. If Kw = 1, the relationship is best
predicted for different [MgATP] if the number (ns) of
independent myosin-binding sites is close to 3 per 36 nm
(Supplementary Fig. S3). If Kw is increased to 12, the
experimental data are instead best predicted with only one
myosin binding site per 36 nm (ns = 1) (Fig. 3). In the
following, Kw = 12 instead of Kw = 1 will be used as
standard value (see further ‘‘Discussion’’ section) together
with ns = 1.
The predicted ATP turnover rate per head (19 s-1) in
the in vitro motility assay is similar to experimental results
(13 s-1 (Uyeda et al. 1990); see also Toyoshima et al.
1990) and constitutes a similar fraction of the actomyosin



















































Fig. 2 Predictions of single
molecule mechanics. a Typical
simulated displacement record
following attachment of single
myosin molecule to actin
filament at zero time. Brownian
noise not simulated. b [MgATP]
dependence of the average
duration of first (t1) and second
(t2) phases of displacement
records like in A. Error bars
SEM. Number of simulated
events given in parentheses.
c The rate constant 1/t2 with (t2
from B without error bars)
plotted vs [MgATP] at
[MgATP]B 0. 1 mM
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ATPase in solution (86 s-1 in experiments (Brenner and
Eisenberg 1986); and 89 s-1 predicted here (see above).
In order to account for the high maximum velocity at
high [MgATP] (Fig. 3) it was necessary to assume a strain-
dependent MgATP-induced detachment rate (k2(x)).
However, the appreciable strain-dependence required is not
consistent with experimental findings (Capitanio et al.
2012; Nyitrai et al. 2006) and also leads to too high
velocity at low [MgATP]. We therefore attempted to
reproduce the data at both low and high [MgATP] with
limited strain-dependence of k2(x) (cf. Fig. 4d in Capitanio
et al. 2012). This was possible if it was also assumed that
the cross-bridge elasticity is non-linear, with low stiffness
of post-power-stroke cross-bridges (Kaya and Higuchi
2010). Such an idea was previously found to improve the fit
to [MgATP]-velocity plots using a biochemically simpler,
large-ensemble model (Persson et al. 2013). It can be seen
(Fig. 3b; ns = 1) that the effect of [MgATP] on maximum
velocity is quite well accommodated without sacrificing
faithful reproduction of the shape of the velocity–length
relationships. This was achieved without other changes
than reduced strain-dependence of k2(x) and introduction
of non-linear cross-bridge elasticity.
Velocity-length data like those in Fig. 3 are often ana-
lyzed by fitting the equation of Uyeda et al. (Uyeda et al.
1990) (Eq. 1; lines in Fig. 3) to obtain an estimate of the
duty ratio. The latter parameter is the fraction of the ATP-
turnover time that a given myosin head spends strongly
attached to actin or, in other words, the fraction of strongly
attached myosin heads at a given time. Fits of Eq. 1 (Uyeda
et al. 1990) to the simulated velocity-length data in Fig. 3
gave duty ratios that correlated positively with the number
of attached myosin heads according to the simulations
(Fig. 3c). However, the duty ratios from fits of Eq. 1 sub-
stantially underestimate (by two to sixfold) the fraction of
attached heads both if linear and non-linear cross-bridge
elasticity (see above) is assumed in the simulations. This is
not surprising because elastic coupling effects are not taken
into account in the Uyeda et al. (1990) equation. In con-
trast, elastic coupling is central in the present model as well
as in previous models for large ensembles and some recent
models for small ensembles (Hilbert et al. 2013; Pate and

















































Fig. 3 Velocity vs filament length in the in vitro motility assay.
a Simulated velocity vs filament length (5000 active myosin heads per
lm2) for standard conditions assuming Kw = 12 (open symbols, full
lines) compared to experimental in vitro motility assay data (filled
symbols; Persson et al. 2013). Simulated and experimental data at
1 mM (black), 0.1 mM (red) and 0.01 mM (blue) [MgATP]. Filled
lines represent fits of Eq. 1 to the simulated data. Dashed lines
represent fits of Eq. 1 to simulation results (not shown) where three
independent myosin binding sites are assumed per 36 nm of the actin
filament. b Simulation results and experimental results for similar
conditions as in A (similar color and format coding of lines and
symbols) but assuming non-linear cross-bridge elasticity (i.e. ks = 2.8
pN/nm for x[ 0 and ks = 0.25 pN/nm otherwise). c Fraction of
attached myosin heads in strongly bound states from simulations
plotted against duty ratio from fit of Eq. 1 to the simulated data. The
strongly bound heads in the simulations were either taken as all heads
in the states AM*DL, AM*DH, AMD, AM and AMT (squares) or
only the heads in the states AM*DH, AMD, AM and AMT (circles).
The cross-bridge elasticity was either assumed to be linear (filled
symbols and full line) or non-linear (open symbols and dashed line).
Horizontal error bars are the 95% CIs obtained in the non-linear
regression fit of Eq. 1 with maximum velocity and duty ratio as
varying parameters in the regression analysis. Dotted line has slope 1.
Similar data as in A and C for Kw = 1 are shown in Supplementary
Fig. S3
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Cooke 1991; Walcott et al. 2012). That is, binding of
myosin heads to actin, but also detachment and other
transitions of attached myosin heads that change total
motor force, influence the strain (and thereby strain-de-
pendent kinetics) of other actin-attached myosin heads.
This is implemented here by re-equilibrating forces fol-
lowing each state transition (see Supplementary Methods).
The functional relationship between the duty ratio (from
Eq. 1) and the number of attached heads at different
[MgATP] was very similar for Kw = 1 and Kw = 12
(Supplementary Fig. S3).
Key results for short actin filaments and low myosin
surface densities are also predicted (Fig. 4) such as the
tendency for stops and pauses in motility, intervened by
periods of rapid sliding when the number of available
myosin heads is reduced below a certain critical value
(Hilbert et al. 2013). Furthermore, in accordance with a
minimum actin filament length of *0.15 lm for main-
tained sliding at a myosin head density of 1000 lm-2
(Toyoshima et al. 1990), extended periods without attached
myosin heads and/or without filament sliding (Fig. 4c),
were observed in simulations under these assumptions.
Model predictions for large actomyosin ensembles were
also compared to experimental data. First, force–velocity
data (Fig. 5a) from fast mouse muscle at 30 C [more
complete, but otherwise similar to rabbit muscle data
(Asmussen et al. 1994)] are well predicted and a small
difference between the simulated and experimental curve is
largely eliminated upon normalization (inset Fig. 5a). This
is important because the force–velocity relationship reflects
an intricate interplay between cross-bridge attachment and
detachment kinetics as well as other features of cross-
bridge operation (Albet-Torres et al. 2009; Duke 1999;
Edman et al. 1997; Hill 1974; Huxley 1957; Piazzesi et al.
2007). The isometric force on average per attached cross-
bridge was 6.95 pN if Kw = 12 and 6.42 pN if Kw = 1.
These values are within the experimental errors of those
(* 6 pN) found in single molecule studies (Capitanio et al.
2012) using myosin preparations from fast mammalian
muscle as well as in experiments on intact muscle fibers
from the frog (Piazzesi et al. 2007). If Kw = 1, as sug-
gested by KM of the actomyosin ATPase (see above), the
maximum power output (load x velocity) would be
underestimated (crosses in Fig. 5a). The normalized force–
velocity relationship would not be changed by increasing ns
from 1 to 3 (not shown) but the average force would
increase threefold.
The simulated effects of altered [Pi] on isometric tension
are approximately consistent with experimental data (Tesi
et al. 2002) (Supplementary Fig. S1D). The prediction that
changed [Pi] does not affect the maximum velocity (see
Supplementary Fig. S1D for details) agrees with experi-
mental findings under physiological pH (Caremani et al.
2013; Cooke and Pate 1985; Debold et al. 2011).
The time course of the isometric tension rise at full
activation is well predicted (Fig. 5b) and is determined
primarily by k?P(x), if the concentration of inorganic
phosphate is low (Dantzig et al. 1992). If Kw&1, the rate of
rise of force would be affected also by Kw because the
quantity Kw k?P(x)/(Kw ? 1) is the effective rate constant
















































































Fig. 4 Plots of displacement (left vertical axis; full line) and number
of attached myosin heads (right axis; dashed line) against time for
filaments propelled by low number of myosin motors. a 0.20 lm long
filament. Note, temporary stops in motility interspersed with phases of
rapid displacement. b One example of simulation assuming 0.15 lm
long filament. c Second example of 0.15 lm long filament. Note,
switch in position upon myosin head attachment but no net
displacement. Assumed motor density, 1000 lm-2 (see ‘‘Materials
and Methods’’ section, text under Eq. 1) corresponding to 4–5 and 6
myosin heads available for interaction with 0.15 and 0.20 lm long
filaments, respectively
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for transition from the MDP to the AM*DL state. However,
it can be seen in Fig. 5b that the effect on the rate of rise of
isometric force of reducing Kw from 12 to 1 would be
difficult to detect within the experimental uncertainty.
In accordance with experiments, the model predicts a
nearly hyperbolic (Michaelis–Menten type) relationship
between [MgATP] and velocity (Fig. 5c) but with lower
KM
v value ([MgATP] at half maximum velocity) than in
experiments. The latter deviation was eliminated, with
maintained velocity at saturating [MgATP], by introduc-
tion of non-linear cross-bridge compliance (cf. Persson
et al. 2013) together with reduced strain-dependence of
k2(x) (Capitanio et al. 2012) (see also Fig. 3b). It is also of
interest to compare the ensemble data in Fig. 5c to the
[MgATP]–velocity relationship predicted by dividing the
step length of 7.7 nm from single molecule data with the
on-times from such data (Fig. 2). It is clear from the dashed
line in Fig. 5c that the latter velocities are almost tenfold
lower than those from ensemble simulations (cf. Bri-
zendine et al. 2015).
A frictional load is often imposed on myosin propelled
filaments in the in vitro motility assay (‘‘a loaded motility
assay’’) (Bing et al. 2000) by transient interaction of actin

































































Fig. 5 Predictions for large ensembles. a Simulated force–velocity
data for muscle under standard conditions with Kw = 12 (black
circles) or Kw = 1 (crosses). Approximate force–velocity relations
deduced using different NEM-HMM/HMM ratios (red) also illus-
trated. The simulated standard data were fitted by the Hill (1938)
hyperbolic equation (black curve). Data compared to experimental
results (purple (Ma˚nsson et al. 1989); see text). Force normalized to
the total number of available heads (whether attached to actin or not).
For Kw = 12 and Kw = 1 average isometric force per attached
myosin head was 6.95 pN and 6.42 pN, respectively. Inset Data
replotted after normalization to maximum velocity and maximum
force. b The rise of isometric force assuming maximum activation
and standard conditions with Kw = 12 (filled circles; rate constant
245 ± 33 s-1 (mean ± 95% CI), in single exponential fit) and
Kw = 1 (crosses; rate constant 152 ± 13 s
-1). Simulations using
Monte-Carlo approach with myosin head surface-density of
5000 lm-2 and filament length of 20 lm. Experimental fit (full
purple line) of data from (Sleep et al. 2005) skinned fast rabbit
skeletal muscle at 20 C (ionic strength: 170 mM) adjusted to 30 C,
assuming Q10-value of 3 or 5 (dashed lines). Experimental data from
intact fast skeletal muscle of the mouse at 30 C (Ma˚nsson et al.
1989) also illustrated (orange line). c Velocity vs [MgATP].
Experimental data from in vitro motility assays (purple; fast rabbit
skeletal muscle HMM, 30 C, ionic strength 130 mM) from (Persson
et al. 2013). It was argued (Persson et al. 2013) that these data are
fully comparable to data from muscle cells. Black filled line and
symbols simulations using standard parameter values and linear cross-
bridge elasticity. Red line and symbols simulations using standard
parameter values (Kw = 12) but assuming low cross-bridge stiffness
(0.25 pN/nm) at negative strain (see text for details). Full curves
represent Michaelis–Menten equation fitted to the data. Black:
KM = 0.123 ± 0.031 mM; Vmax = 14 010 ± 830 nm/s. Purple:
KM = 0.387 ± 0.062 mM; Vmax = 15 408 ± 715 nm/s. Red:
KM = 0.371± 0.27 mM; Vmax = 16 010 ± 330 nm/s. Black open
symbols and connecting dashed lines: Velocity vs [MgATP] assuming
a total step length of 7.7 nm and on-times as in Fig. 2, i.e. using data
from single molecule mechanics. Note Appreciably lower velocity at
all [MgATP] than in simulations for large ensembles
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Simulations, assuming NEM-HMM to be the actin-binding
protein, are consistent with experiments within the quite
appreciable variability (Fig. 6). Furthermore, plots of
velocities against the resistive loads produced by the NEM-
HMM heads compare well to force–velocity data from
simulations of forces developed during iso-velocity short-
ening (Fig. 5).
Discussion
General issues: relation to other studies
A key finding is that a classical model, of the Huxley–Hill
type (Hill 1974; Huxley 1957) with detailed biochemical
cycle (Fig. 1) approximates a range of contractile phe-
nomena (e.g. Figs. 2, 3, 4, 5, 6; Supplementary Fig. S1) on
experimental scales from single molecules to muscle,
without considering details of muscle structure. Related,
there is no need to assume emergent properties in the large
ordered ensembles or to use different models for different
conditions (e.g. Baker et al. 2002).
Steps towards including elastic coupling effects in the
modelling of in vitro motility assay results have been taken
previously (Baker et al. 2002; Duke 1999; Pate and Cooke
1991; Walcott et al. 2012; Vilfan and Duke 2003). Pate and
Cooke (1991) used a slightly modified version of the
(Huxley 1957) model to provide general insights into
effects of varying number of motors but without detailed
connection to key biochemical intermediates in actomyosin
ATP turnover. The latter details are likely to be important
in studies of pathologies but also for full understanding of
normal function. More recent models have included addi-
tional details and provided further insight e.g. about the
behavior of filaments at very low motor number (Hilbert
et al. 2013).They have also reported effects of elastic
coupling on the relationship between the number of motors
and the average motor on-time, sliding distance and
velocity (Baker et al. 2002; Walcott et al. 2012). However,
unlike the present work, the previous studies did not con-
sider all hierarchical levels from single molecules to
muscle cells. Furthermore, the explicit separation of the Pi-
release from both the main force-generating transition and
the attachment step to actin, distinguishes the present
model from most predecessors both for large (Ma˚nsson
2010; Pate and Cooke 1989; Persson et al. 2013) and small
(Erdmann and Schwarz 2012; Hilbert et al. 2013; Pate and
Cooke 1991; Walcott et al. 2012) ensembles. Whereas such
separation is not essential to approximately fit the data in
Fig. 5 (e.g. (Pate and Cooke 1989; Persson et al. 2013) the
results demonstrate that a separate Pi-release and a realistic
biochemical cycle does not compromise the capability of
the model to account for a range of mechanical results on
different scales (Figs. 2, 3, 4, 5, 6). This is important (e.g.
Malnasi-Csizmadia and Kovacs 2010; Ma˚nsson et al. 2015)
in order for a model to be useful for connecting bio-
chemical transitions to mechanical events in fundamental
studies and for elucidating effects of disease-causing
mutations and effects of drugs. A separate Pi-release seems
essential to account for structural and biochemical findings
(Llinas et al. 2015; Sweeney and Houdusse 2010). Further,
it seems required to account for findings in muscle fiber
studies, e.g. the tension response of changes in temperature
(temperature transients) (Ranatunga 2010) and to rapid
changes in the concentration of inorganic phosphate
(phosphate transients) (Dantzig et al. 1992).
Directly related to the above issue, the present study also
differs from most earlier model studies by explicitly con-
sidering a weakly bound actomyosin state (AMDP) that is
distinguished from a start of the power-stroke state without
Pi (AM*DL). The properties of the weakly bound AMDP
state have potentially important implications motivating
that it is considered separately. For instance, different
affinities of this state to actin noticeably affect (Fig. 5A)
the force–velocity relationship. Furthermore, cross-bridges
in the weakly bound state may also impose a viscoelastic
load on actin filaments with a magnitude that varies with
the experimental conditions and possibly between muscle
cells and in vitro motility assays (Homsher et al. 1992)
(however see Vikhorev et al. 2008). Finally, certain myosin
head mutations [e.g. positively charged amino acids in
surface loops (Colegrave and Peckham 2014)] may affect
the weak-binding properties. It is therefore important to
















Fig. 6 Sliding velocity in the in vitro motility assay vs [NEM-
HMM]/[HMM] ratio where NEM-HMM is N-ethyl maleimide treated
HMM. Simulated data (black) compared to experimental data
(purple) from (Kim et al. 1996) (circles; fast rabbit HMM; 25 C;
ionic strength\50 mM) and (Amitani et al. 2001) (triangles, fitted
with cubic polynomial; fast rabbit HMM, 25 C; ionic strength
\50 mM). Simulated behavior of long (20 lm) filaments assuming
binding energy of NEM-HMM to actin of either 18 kBT (filled circles)
or 7 kBT (open circles). The latter case also simulated for 1 lm long
filaments (triangles). Note appreciable variability among experimen-
tal results but also variability among simulated data depending on
exact conditions for the simulations. Experimental data points were
obtained by measuring from figures in the cited papers
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include the weakly bound state in a model intended to be
useful for studies of diseases and drug development.
Uncertainties regarding the actin affinity in the weak-
binding state and their implications are considered below.
The present model overcomes existing barriers in data
interpretation by allowing integration of results from
experimental systems on different scales. Particularly,
mechanical and kinetic results obtained using isolated
proteins, e.g. solution studies, studies of single molecules
or in vitro motility assays (Aksel et al. 2015; Sung et al.
2015; Wang et al. 2013), may be readily extrapolated to
contractile properties of muscle. This will aid mechanistic
insights into the physiology, pathology and pharmacology
of striated muscle contraction. Whereas the model is lar-
gely based on states derived from mechanical experiments
and biochemical kinetics, the states have coarse-grain
structural equivalents, e.g. with lever arm up or down
(insets of Fig. 1b) and the actin-binding cleft open or
closed. Therefore, the model should be useful for corre-
lating atomic resolution structural data (e.g. reviewed in
Sweeney and Houdusse (2010), Ma˚nsson et al. (2015)) and
contractile function from single molecules to large acto-
myosin ensembles.
For studies of pathologies, additional states, e.g. the so
called super-relaxed state (Hooijman et al. 2011; Linari
et al. 2015) may be important to include as well as effects of
regulatory proteins and time varying activation. Inclusion of
new states into the model is trivial. It is more complex to
include time varying activation. This property is attributed
to regulatory/modulatory proteins associated both with the
thin filaments (troponin, tropomyosin) and the thick fila-
ments, e.g. myosin regulatory light chains and myosin
binding protein C (reviews in Kamm and Stull 2011; Moore
et al. 2016; van Dijk et al. 2014). The issue may be treated
either phenomenologically by time varying values of rate
constants (Homsher et al. 2000; Ma˚nsson 2014; Webb et al.
2013) or explicitly using expanded Monte-Carlo approa-
ches (Mijailovich et al. 2012; Rice and de Tombe 2004).
However, due to computation time constraints, the latter
approach will require extensive optimization for speed both
of computational platforms and algorithms.
The effect of lengthening during activity is not in focus
here. However, this is an important physiological phe-
nomenon that also needs to be taken into account when
studying e.g. pathologies (Ma˚nsson 2014). A simple
approach to account for key aspects of the mechanics of
lengthening contraction is therefore illustrated in Supple-
mentary Fig. S4. However, undoubtedly, both effects of
other proteins than actin and myosin e.g. titin, and emer-
gent properties related to sarcomere non-uniformities will
need to be considered in a complete treatment (Campbell
et al. 2011; Edman 2012; Higuchi and Umazume 1985;
Rassier 2012a; Wang et al. 1984).
Limitations of the model: related biological insights
and suggestions for further studies
As mentioned above, no attempts were made to fit condi-
tions of time-varying activation or lengthening contrac-
tions. However, additional experimental results are not
accounted for in full quantitative detail. This may either be
attributed to experimental uncertainties or limitations in the
model representation of biological mechanisms. Such
limitations necessarily exist in any model and are important
because they point out poorly understood mechanisms and
prompt testing of alternative ideas. Below, the discrepancy
between predictions of the present model and experimental
data is considered in relation to experimental uncertainties
and alternative models.
One limitation related to poorly understood character-
istics of the cross-bridge elasticity (whether it is linear or
non-linear) is the requirement for significantly greater
strain/load dependence of k2 in the model than suggested
by the load-dependence of the ATP-induced detachment in
single molecule measurements (Capitanio et al. 2012;
Supplementary Fig. S2). This was necessary to account for
the high maximal velocity at saturating [MgATP] but led to
overestimation of velocity at lower [MgATP] (with too low
KM
v -value). Interestingly, however, both the magnitudes of
the maximum velocity and KM
v for the [MgATP]–v rela-
tionship are accounted for with very low (or no) strain
dependence of k2 if the cross-bridge compliance for
x\ 0 nm is assumed to be *1/10 of that at x[ 0 nm,
simulating non-linear cross-bridge elasticity (Kaya and
Higuchi 2010). On the other hand, evidence suggesting a
non-linear elasticity has been obtained only in certain
in vitro assays (Brizendine et al. 2015; Kaya and Higuchi
2010; Persson et al. 2013) and there is currently no firm
evidence that the cross-bridge elasticity is non-linear in
muscle cells. Clearly, the latter issue will be of outmost
importance to clarify.
One further problem is that the detailed course of events
associated with transitions between the MDP and the
AM*DL states cannot be represented in full detail due to
ambiguities in available experimental data (reviewed in
Ma˚nsson et al. 2015). These poorly understood details
might account for the failure to perfectly reproduce the
relationship between [Pi] and isometric tension as well as
for lack of key ATP-independent detachment processes in
single molecule data (Capitanio et al. 2012). The latter
findings seem to suggest additional states between the
AMDP and the AM*DL states. Here, it is of interest to
consider ideas (Caremani et al. 2013; Ford et al. 1986;
Geeves et al. 1984; Smith and Mijailovich 2008) that
mechanical transitions between high force and low force
conformations occur in different biochemical states. For
instance, a mechanical transition (similar to that from the
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AM*DL to AM*DH state) may occur also in an AM*DP
biochemical state. This would add a high-force state from
which rapid ATP independent detachment may occur.
Additionally, it would fit with at least two tensing steps as
suggested recently (Offer and Ranatunga 2013) and it may
fit into a framework to explain high maximum power-
output of muscle (Caremani et al. 2013) without the need
for a high value of Kw as used here. However, again, the
available experimental data is ambiguous with regard to
both the existence and the properties of these postulated
states and transitions (Ma˚nsson et al. 2015).
One additional reason for discrepancies between the
model predictions and experimental results (Capitanio
et al. 2012) for load-dependence of cross-bridge detach-
ment (Supplementary Fig. S2) could be that the model is
defined primarily on the basis of data for two-headed
myosin whereas the experiments use one-headed myosin.
Peculiarities in relation to other experimental results (see
Supplementary Fig. S2) lend support to that idea.
As discussed above, the weakly bound myosin state is
not included as a separate state in most models. The
striking effects of a tenfold change in actin affinity is
therefore of interest. For instance, the need to assume a
higher value of Kw to account for high power-output of
muscle than expected from actin-binding in solution (as-
sociation constant Ka), could mean that cooperative or
other phenomena operate during shortening against inter-
mediate loads (Caremani et al. 2013; Edman et al. 1997;
Ma˚nsson 2010). On the other hand, there may be some
uncertainty (Brenner et al. 1986; Eisenberg et al. 1980) in
the effective actin concentration, in the muscle sarcomere,
which relates Kw to Ka. Alternatively, the affinity of
weakly bound actomyosin cross-bridges might vary
between conditions as suggested for actomyosin bonds in
other states (Guo and Guilford 2006). Further, as an
additional alternative, the surface attachment of myosin
motors, either to the motility assay surface or the thick
filament backbone, may account for increased affinity of
the weakly bound actomyosin state in mechanical experi-
ments. It would therefore be valuable if current estimates
of the affinity of weakly bound heads with myosin tethered
on a surface are verified under physiological conditions and
full activation.
Implications for the interpretation of in vitro
motility assay data at different motor densities
In terms of the model of Uyeda et al.(1990) (Eq. 1) the
velocity varies with the number (N) of available motors
due to the fraction of time that at least one motor propels
the actin filament; no elastic coupling effects between
motors are considered as in classical muscle models (Hill
1974; Huxley 1957). The present study and the results in
recent work (Walcott et al. 2012) strongly suggest that, if
such elastic coupling is present, the parameter values
obtained in fits of Eq. 1 (Uyeda et al. 1990) do not ade-
quately describe the system. This is important because of
the extensive use of the Uyeda model (Uyeda et al. 1990)
for analysis of in vitro motility assay data. The present
results (Fig. 3) accord with 1–3 myosin binding sites per
36 nm of the actin filament which indicates that myosin
heads only bind to target zones at 36 nm spacing. This
accords with single molecule mechanics data (Capitanio
et al. 2006; Steffen et al. 2001) but is generally not con-
sidered in the analysis of in vitro motility assays for small
ensembles.
Relation to engineering approaches involving
actomyosin
An interesting development in the recent decade is engi-
neering of myosin motors to incorporate radically new
functionalities, e.g. with regard to the movement direction
along actin filaments (Tsiavaliaris et al. 2004) or even the
remote switching of this directionality, e.g. by illumination
(Nakamura et al. 2014). In addition to potential uses in
nanotechnological applications (Kumar et al. 2016; Ma˚n-
sson 2012; Nicolau et al. 2016) the engineering results pose
new questions about how certain functions relate to struc-
tural elements in the motor. The present model, by virtue of
coarse-grain structural equivalence of different states,
would be useful for elucidating how the engineered ele-
ments give rise to some of their functional consequences.
Conversely, the model may also be useful for guiding
engineering of motors with certain properties, e.g. for use
in nanotechnology.
Conclusions
The results demonstrate that actomyosin contractile func-
tion, from single molecules to large ensembles, is reason-
ably well approximated by one unifying chemo-mechanical
model with a realistic biochemical cycle. Observed limi-
tations in model predictions identify needs for new
experimental studies. This includes the transitions between
the MDP state over the weak-binding actomyosin state to
the start of power-stroke AM*DL state, i.e. the properties of
the weakly bound actomyosin state and the temporal rela-
tionship between Pi-release and the main force-generating
transition. Furthermore, detailed characterization of the
cross-bridge elasticity is essential. Particularly, it is
important to clarify if non-linear elasticity is limited to
certain in vitro assays or is present in living muscle. A
future version of the model for analysis of diseases and
drug effects would benefit from new experimental evidence
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to fully clarify the mentioned issues. Finally, the study has
also given new insights important for the interpretation of
in vitro motility assays and for engineering of motors.
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